Top compounds associated with response to MYO19


Feature Type Standardized
Nominal ANOVA
mRNA MLN4924 CTRPv2 pan-cancer AAC 0.063 0.08
mRNA BMS-754807 CTRPv2 pan-cancer AAC 0.063 0.08
mRNA Cetuximab GDSC1000 pan-cancer AAC -0.057 0.09
mRNA Roscovitine GDSC1000 pan-cancer AAC -0.096 0.09
mRNA T0901317 GDSC1000 pan-cancer AAC -0.058 0.09
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.059 0.09
mRNA piperlongumine:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.064 0.09
mRNA BRD-K75293299 CTRPv2 pan-cancer AAC -0.13 0.09
mRNA Epothilone B GDSC1000 pan-cancer AAC 0.06 0.09
mRNA neopeltolide CTRPv2 pan-cancer AAC 0.12 0.09
Download CSV